204 related articles for article (PubMed ID: 34244112)
1. The effect of age on health-related quality of life for head and neck cancer patients up to 1 year after curative treatment.
Berg M; Silander E; Bove M; Johansson L; Nyman J; Hammerlid E
J Geriatr Oncol; 2022 Jan; 13(1):60-66. PubMed ID: 34244112
[TBL] [Abstract][Full Text] [Related]
2. Fatigue in Long-Term Head and Neck Cancer Survivors From Diagnosis Until Five Years After Treatment.
Berg M; Silander E; Bove M; Johansson L; Nyman J; Hammerlid E
Laryngoscope; 2023 Sep; 133(9):2211-2221. PubMed ID: 36695154
[TBL] [Abstract][Full Text] [Related]
3. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
Parkar S; Sharma A; Shah M
J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
[TBL] [Abstract][Full Text] [Related]
4. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
5. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
[TBL] [Abstract][Full Text] [Related]
6. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
Taylor KJ; Amdal CD; Bjordal K; Astrup GL; Herlofson BB; Duprez F; Gama RR; Jacinto A; Hammerlid E; Scricciolo M; Jansen F; Verdonck-de Leeuw IM; Fanetti G; Guntinas-Lichius O; Inhestern J; Dragan T; Fabian A; Boehm A; Wöhner U; Kiyota N; Krüger M; Bonomo P; Pinto M; Nuyts S; Silva JC; Stromberger C; Specenier P; Tramacere F; Bushnak A; Perotti P; Plath M; Paderno A; Stempler N; Kouri M; Grégoire V; Singer S;
Int J Cancer; 2024 May; 154(10):1772-1785. PubMed ID: 38312044
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module.
Kaufmann A; Schmidt H; Ostheimer C; Ullrich J; Landenberger M; Vordermark D
Support Care Cancer; 2015 Jul; 23(7):1883-92. PubMed ID: 25475738
[TBL] [Abstract][Full Text] [Related]
8. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM
PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
11. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144
[TBL] [Abstract][Full Text] [Related]
12. Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
Noel CW; Stephens RF; Su JS; Xu W; Krahn M; Monteiro E; Goldstein DP; Giuliani M; Hansen AR; de Almeida JR
Head Neck; 2020 Sep; 42(9):2277-2286. PubMed ID: 32333829
[TBL] [Abstract][Full Text] [Related]
13. Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer.
Kinoshita Y; Izukura R; Kishimoto J; Kanaoka M; Fujita H; Ando K; Nagai S; Akiyoshi S; Tagawa T; Kubo M; Inokuchi J; Ohuchida K; Oki E; Tanaka K; Eto M; Yoshizumi T; Nakamura M; Chishaki A
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4899-4914. PubMed ID: 36307557
[TBL] [Abstract][Full Text] [Related]
14. Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study.
Degboe A; Knight SL; Halling K; Trigg A; Al-Zubeidi T; Aldhouse N; Kitchen H; Wirth L; Rogers SN
J Patient Rep Outcomes; 2017; 2():33. PubMed ID: 30148250
[TBL] [Abstract][Full Text] [Related]
15. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
16. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
17. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer.
Wheelwright S; Darlington AS; Fitzsimmons D; Fayers P; Arraras JI; Bonnetain F; Brain E; Bredart A; Chie WC; Giesinger J; Hammerlid E; O'Connor SJ; Oerlemans S; Pallis A; Reed M; Singhal N; Vassiliou V; Young T; Johnson C
Br J Cancer; 2013 Aug; 109(4):852-8. PubMed ID: 23868003
[TBL] [Abstract][Full Text] [Related]
18. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
Hammerlid E; Adnan A; Silander E
Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after different treatment modalities for carcinoma of the oropharynx.
Tschudi D; Stoeckli S; Schmid S
Laryngoscope; 2003 Nov; 113(11):1949-54. PubMed ID: 14603054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
